XML 78 R16.htm IDEA: XBRL DOCUMENT v2.4.0.6
Earnings Per Share Attributable to Common Shareholders
9 Months Ended
Sep. 30, 2012
Earnings Per Share [Abstract]  
Earnings Per Share Attributable to Common Shareholders
Earnings Per Share Attributable to Common Shareholders

The following table provides the detailed calculation of Earnings per share:
 
 
Three Months Ended
 
Nine Months Ended
(IN MILLIONS)
 
September 30,
2012

 
October 2,
2011

 
September 30,
2012

 
October 2,
2011

EPS Numerator––Basic
 
 
 
 
 
 
 
 
Income from continuing operations
 
$
3,110

 
$
2,325

 
$
8,028

 
$
6,982

Less: Net income attributable to noncontrolling interests
 
6

 
11

 
22

 
31

Income from continuing operations attributable to Pfizer Inc.
 
3,104

 
2,314

 
8,006

 
6,951

Less: Preferred stock dividends––net of tax
 
1

 

 
1

 
1

Income from continuing operations attributable to Pfizer Inc.
common shareholders
 
3,103

 
2,314

 
8,005

 
6,950

Discontinued operations––net of tax
 
104

 
1,424

 
249

 
1,619

Net income attributable to Pfizer Inc. common shareholders
 
$
3,207

 
$
3,738

 
$
8,254

 
$
8,569

EPS Numerator––Diluted
 
 

 
 

 
 

 
 

Income from continuing operations attributable to Pfizer Inc. common shareholders and assumed conversions
 
$
3,104

 
$
2,314

 
$
8,006

 
$
6,951

Discontinued operations––net of tax
 
104

 
1,424

 
249

 
1,619

Net income attributable to Pfizer Inc. common shareholders and assumed conversions
 
$
3,208

 
$
3,738

 
$
8,255

 
$
8,570

EPS Denominator
 
 

 
 

 
 

 
 

Weighted-average number of common shares outstanding––Basic
 
7,436

 
7,770

 
7,483

 
7,877

Common-share equivalents: stock options, stock issuable under employee compensation plans and convertible preferred stock
 
72

 
40

 
67

 
48

Weighted-average number of common shares outstanding––Diluted
 
7,508

 
7,810

 
7,550

 
7,925

Stock options that had exercise prices greater than the average market price of our common stock issuable under employee compensation plans(a)

180

 
342

 
180

 
279

(a) 
These common stock equivalents were outstanding for the three and nine months ended September 30, 2012 and October 2, 2011, but were not included in the computation of diluted EPS for those periods because their inclusion would have had an anti-dilutive effect.